Skip to content

The impact of mindfulness on COVID-19 patients during the COVID-19 pandemic: a randomized controlled trial

The impact of mindfulness on COVID-19 patients during the COVID-19 pandemic: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053822
Enrollment
Unknown
Registered
2021-11-30
Start date
2021-10-16
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Intervention group:Mindfulness for stress reduction
Control group:Routine care

Sponsors

Yangzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet key diagnostic criteria for severe COVID-19; 2. Aged between 20 and 80 years, no gender limit; 3. Stable condition, conscious and cooperative spirit in the intervention; 4. Voluntarily participate in the trial and sign the informed consent; 5. Commitment not to perform other exercise programs.

Exclusion criteria

Exclusion criteria: 1. Patients with chronic obstructive pulmonary disease, obstructive pulmonary disease, coronary heart disease, hypertension and other serious underlying disease complications; 2. Severe mentally ill patients; 3. Patients with respiratory failure who need mechanical ventilation or patients with shock or combined organ failure who need monitoring and treatment in the intensive care unit; 4. Pregnant patients and lactating patients; 5. Patients participating in other forms of exercise during the trial.

Design outcomes

Primary

MeasureTime frame
Resilience;

Secondary

MeasureTime frame
Disease perception;

Countries

China

Contacts

Public ContactZhu Pingting

Yangzhou University

ptzhu@yzu.edu.cn+86 13773566199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026